Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed Phase I trialsSAN DIEGO and...
NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a...
BERKELEY HEIGHTS, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform...
Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation...
SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that eight abstracts highlighting new...
CAMBRIDGE, Mass., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies...
ATLANTA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is...
REDWOOD CITY, Calif., Oct. 11, 2023 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel,...
– Live moderated webcast with Klaus Paulini, Chief Executive Officer of Aeterna Zentaris on Wednesday, October 25th at 10:00 AM...
Toronto, Ontario--(Newsfile Corp. - October 10, 2023) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading...
RALEIGH, NC / ACCESSWIRE / October 10, 2023 / iCare, a trusted partner in ophthalmic management based out of Finland,...
Significant milestone marking the beginning of VINIA® geographical expansion beyond Israel and the US Further validation from global health authorities...
Patent Protects PBIO's Exclusive Rights to Commercialize UltraShear Platform in Canada, Leveraging Unique, Best-in-Class Nanoemulsions Processing Performance with Full Commercial...
SAN DIEGO, CA / ACCESSWIRE / October 10, 2023 / Rancho BioSciences, the leading Data Science Services company based in...
Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDASAN...
Salix Pharmaceuticals' Liver Health Annual Trends Report Findings Suggest Chronic Liver Disease (CLD) Deaths Could Triple Before the End of...
TARRYTOWN, NY / ACCESSWIRE / October 10, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a clinical stage biopharmaceutical company focusing on the...
EcoVadis Award reflects Nelipak’s Commitment to Help Healthcare Be SustainableCRANSTON, R.I., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Nelipak Corporation (“Nelipak”),...
Veteran Life Sciences Executives Bring Extensive Public Company Operating Experience to Leadership TeamCINCINNATI, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Blue...